Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.22 AUD 4.76% Market Closed
Market Cap: 121.3m AUD
Have any thoughts about
Medadvisor Ltd?
Write Note

Medadvisor Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medadvisor Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Medadvisor Ltd
ASX:MDR
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
Cash Equivalents
AU$18.9m
CAGR 3-Years
22%
CAGR 5-Years
70%
CAGR 10-Years
42%
4DMedical Ltd
ASX:4DX
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Cash Equivalents
$30.1m
CAGR 3-Years
8%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medibio Ltd
ASX:MEB
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medadvisor Ltd
Glance View

Market Cap
121.1m AUD
Industry
Health Care

MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..

MDR Intrinsic Value
0.28 AUD
Undervaluation 21%
Intrinsic Value
Price

See Also

Back to Top